Cardiomyocyte-targeted overexpression of the coxsackie-adenovirus receptor causes a cardiomyopathy in association with β-catenin signaling

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 6, 2010, Pages 1194-1205

  Caruso, Laura ^a   Yuen, Stella ^a   Smith, Julie ^a   Husain, Mansoor ^b,c   Opavsky, Mary Anne ^a,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Akt; Beta catenin; Cadherin; Cardiomyopathy; Coxsackie adenovirus receptor

Indexed keywords

BETA CATENIN; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; MYC PROTEIN; NERVE CELL ADHESION MOLECULE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL DEGENERATION; CONTROLLED STUDY; DISEASE SEVERITY; EMBRYO; GENE EXPRESSION; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HUMAN; HUMAN CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; TRANSGENE;

ANIMALS; BETA CATENIN; CADHERINS; CARDIOMYOPATHIES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; HYPERTROPHY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, VIRUS; SARCOLEMMA;

ADENOVIRIDAE; MURINAE; MUS; MUS MUSCULUS;

EID: 77952669050     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.01.022     Document Type: Article

References (55)

1. Coyne C., Bergelson J. CAR: a virus receptor within the tight junction. Adv Drug Deliv Rev 2005, 57:869-882.
2. Noutsias M., Fechner H., de Jonge H., Wang X., Dekkers D., Houtsmuller A., et al. Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation 2001, 104:275-280.
3. Walters R., Freimuth P., Moninger T., Ganske I., Zabner J., Welsh M. Adenovirus fiber disrupts CAR-mediated intercelllular adhesion allowing virus escape. Cell 2002, 110:789-799.
4. Cohen C.J., Sheih J., Pickles R.J., Okegawa T., Hsieh J., Bergelson J. The coxsackie virus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci U S A 2001, 98:15191-15196.
5. Bergelson J.M., Cunningham J.A., Droguett G., Horwitz M.S., Wickham T., Crowell R.L., et al. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275:1320-1323.
6. Tomko R., Xu R., Philipson L. HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc Natl Acad Sci U S A 1997, 94:3352-3356.
7. Honda T., Saitoh H., Masuko M., Katagiri-Abe T., Tominaga K., Kozakai I., et al. The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain. Brain Res Mol Brain Res 2000, 77(1):19-28.
8. Kashimura T., Kodama M., Hotta Y., Hosoya J., Yoshida K., Ozawa T., et al. Spatiotemporal changes of coxsackievius and adenovirus receptor in rat hearts during postnatal development and in cultured cardiomyocytes of neonatal rat. Virchows Arch 2004, 444:283-292.
9. Asher D., Cerny A., Weiler S., Horner J., Keeler M., Neptune M., et al. Coxackie and adenovirus receptor is essential for cardiomyocyte development. Genesis 2005, 42:77-85.
10. Chen J., Zhou B., Yu Q., Shin S., Jiao K., Schneider M., et al. Cardiomyocyte-specific deletion of the coxsackievirus and adenovirus receptor results in hyperplasia of the embryonic left ventricle and abnormalities of sinuatrial valves. Circ Res 2006, 98:923-930.
11. Dorner A., Wegmann F., Butz S., Wolburg-Buchholz K., Wolburg H., Mack A., et al. Coxsackie-adenovirus receptor (CAR) is essential for early embryonic cardiac development. J Cell Sci 2005, 118:3509-3521.
12. Lim B.-K., Xiong D., Dorner A., Youn T.-J., Yung A., Liu T., et al. Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. J Clin Invest 2008, 118:2758-2770.
13. Sasse A., Wallich M., Ding Z., Goedecke A., Schrader J. Coxsackie-and-adenovirus receptor mRNA expression in human heart failure. J Gene Med 2003, 5:876-882.
14. Ito M., Kodama M., Masuko M., Yamaura M., Fuse K., Uesugi Y., et al. Expression of coxsackievirus and adenovirus receptor in hearts of rats with experimental autoimmune myocarditis. Circ Res 2000, 86:275-280.
15. Fechner H., Noutsias M., Tschoepe C., Hinze K., Wang X., Escher F., et al. Induction of coxsackievirus-adenovirus-receptor expression during myocardial tissue formation and remodeling. Identification of a cell-to-cell contact-dependent regulatory mechanism. Circulation 2003, 107:876-882.
16. Lisewski U., Shi Y., Wrackmeyer U., Fischer R., Chen C., Schirdewan A., et al. The tight junction protein CAR regulates cardiac conduction and cell-cell communication. J Exp Med 2009, 205(10):2369-2379.
17. Xiao G., Mao S., Baumgarten G., Serrano J., Jordan M., Roos K., et al. Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ Res 2001, 89:1122-1129.
18. Mungrue I., Gros R., You X., Pirani A., Azad A., Csont T., et al. Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. J Clin Investig 2002, 109:735-743.
19. Ju H., Gros R., You X., Tsang S., Husain M., Rabinovitch M. Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice. Proc Natl Acad Sci U S A 2001, 98(13):7469-7474.
20. Martino T., Petric M., Weingartl H., Bergelson J., Opavsky M., Richardson C., et al. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 2000, 271:99-108.
21. Yu Z., Redfern C., Fisman G. Conditional transgene expression in the heart. Circ Res 1996, 79:691-697.
22. You X.-M., Mungrue I., Kalair W., Afroze T., Ravi B., Sadi A., et al. Conditional expression of a dominant-negative c-Myb in vascular smooth muscle cells inhibits arterial remodeling after injury. Circ Res 2003, 92:314-321.
23. Opavsky M.A., Penninger J., Aitken K., Wen W.-H., Dawood F., Mak T., et al. Susceptibility to myocarditis is dependent on the response of alpha beta T lymphocytes to coxsackieviral infection. Circ Res 1999, 85:551-558.
24. Opavsky M.A., Martino T., Rabinovitch M., Penninger J., Richardson C., Petric M., et al. Enhanced ERK1/2 activation in mice susceptible to coxsackievirus-induced myocarditis. J Clin Invest 2002, 109:1561-1569.
25. Brown J., Fung C., Tailor C. Comprehensive mapping of receptor-functioning domains in feline leukemia virus subgroup C receptor FLVCR1. J Virol 2006, 80(4):1742-1751.
26. Haq S., Michael A., Andreucci M., Bhattacharya K., Dotto P., Walters B., et al. Stablilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci U S A 2003, 100(8):4610-4615.
27. Pfaffl M. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29(2):2002-2007.
28. Spandidos A., Wang X., Wang H., Dragnev S., Thurber T., Seed B. A comprehensive collection of experimentally validated primers for polymerase chain reaction quantitation of murine transcript abundance. BMC Genomics 2008, 9:633.
29. Wang X., Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 2003, 31(24):e154. [1-8].
30. Shaw C., Holland P., Sinnreich M., Allen C., Sollerbrant K., Karpati G., et al. Isoform-specific expression of the coxsackie and adenovirus receptor (CAR) in neuromuscular junction and cardiac intercalated discs. BMC Cell Biol 2004, 5:1-8.
31. Sollerbrant K., Raschperger E., Mirza M., Engstrom U., Philipson L., Ljungdahl P., et al. The coxsackievirus and adenovirus receptor (CAR) forms a complex with the PDZ domain-containing protein ligand-of-numb protein-X (LNX). J Biol Chem 2003, 278:7439-7444.
32. Bruning A., Runnenbaum I. CAR is a cell-cell adhesion protein in human cancer cells and is espressionally modulated by dexamethasone, TNFα and TGFβ Gene Ther 2003, 10:198-205.
33. Pickles R.J., Fahrner J.A., Petrella J.M., Boucher R.C., Bergelson J.M. Retargeting the coxsackievirus and adenovirus receptor to the apical surface of polarized epithelial cells reveals the glycocalyx as a barrier to adenovirus-mediated gene transfer. J Virol 2000, 74(13):6050-6057.
34. Gates J., Peifer M. Can 1000 reviews be wrong? Actin, alpha-catenin, and adherens junctions. Cell 2005, 123:769-772.
35. Harris T., Peifer M. Decisions, decisions: α-catenin chooses between adhesion and transcription. Trends Cell Biol 2005, 15(5):234-237.
36. Shetskov S., Haq S., Force T. Activation of α-catenin signaling pathways by classical G-protein coupled receptors. Cell Cycle 2006, 5(20):2295-2300.
37. Moon R., Kohn A., DeFerrari G., Kaykas A. Wnt and α-catenin signalling: diseases and therapies. Nat Rev Genet 2004, 5:689-699.
38. Sugden P., Fuller S., Weiss S., Clerk A. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis. Br J Pharmacol 2008, 153:S137-S153.
39. Fang D., Hawke D., Zheng Y., Xia Y., Meisenhelder J., Nika H., et al. Phosphorylation of α-catenin by AKT promotes b-catenin transcriptional activity. J Biol Chem 2007, 282(15):11221-11229.
40. Chen X., Shevtsov S., Hsich E., Cui L., Haq S., Aronovitz M., et al. The {beta}-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophy. Mol Biol Cell 2006, 26(12):4462-4473.
41. Baurand A., Zelarayan L., Betney R., Gehrke C., Dunger S., Noack C., et al. α-catenin downregulation is reqeuired for adaptive cardiac remodeling. Circ Res 2007, 100:1353-1362.
42. Zhou J., Qu J., Yi X., Graber K., Huber L., Wang X., et al. Upregulation of {gamma}-catenin compensates for the loss of beta-catenin in adult cardiomyocytes. Am J Physiol Heart Circ Physiol 2007, 292(1):H270-H276.
43. Zhong W., Mao S., Tobis S., Angelis E., Jordan M., Roos K., et al. Hypertrophic growth in cardiac myocytes is mediated by myc through a cyclin D2-dependent pathway. EMBO J 2006, 25:3869-3879.
44. Jiao K., Kulessa H., Tompkins K., Zhou Y., Batts L., Baldwin H., et al. An essential role of Bmp4 in the atrioventricular sepatation of the mouse heart. Genes Dev 2003, 17:2362-2367.
45. Klaus A., Birchmeier A. Developmental signaling in myocardial progenitor cells: a comprehensive view of Bmp- and Wnt/α-catenin signaling. Pediatr Cardiol 2009, 30:609-616.
46. Bellacosa A., Testa J., Staal S., Tsichlis P. A retroviral oncogene, akt, encoding a serine-threonine kinase containing an SH2-like region. Science 1991, 254:274-277.
47. Meier R., Alessi D., Cron P., Andjelkovic M., Hemmings B. Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta. J Biol Chem 1997, 272:30491-30497.
48. O'Neill B., Abel E. Akt1 in the cardiovascular system: firend or foe?. J Clin Invest 2005, 115(8):2059-2064.
49. Matsui T., Nagoshi T., Rosenzweig A. Akt and PI 3-kinase signaling in cardiomyocyte hypertrophy and survival. Cell Cycle 2003, 220-223.
50. Condorelli G., Drusco A., Stassi G., Bellacosa A., Roncarati R., Iaccarino G., et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A 2002, 99:12333-12338.
51. Taniyama Y., Ito M., Keuster C., Veit K., Tremp G., et al. Akt3 overexpression in the heart results in progression from adaptive to maladaptive hypertrophy. J Mol Cell Cardiol 2005, 38:375-385.
52. Shioi T., McMullen J., Kang P., Douglas P., Obata T., Franke T., et al. Akt/protein kinase B promotes organ growth in transgenic mice. Mol Biol Cell 2002, 22:2799-2809.
53. Ferreira-Cornwell M., Luo Y., Narula N., Lenox J., Leiberman M., Radice G. Remodeling the intercalated disc leads to cardiomyopathy in mice misexpressing cadherins in the heart. J Cell Sci 2002, 115:1623-1634.
54. Perriard J.-C., Hirschy A., Ehler E. Dilated cardiomyopathy: a disease of the intercalated disc?. Trends Cardiovasc Med 2003, 13:30-38.
55. Kostetskii I., Li J., Xiong Y., Zhou R., Ferrari V., Patel V., et al. Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res 2005, 96:346-354.